# Quick Heal Technologies share price today (Quick Heal Technologies Ltd, NSE: QUICKHEAL)

> Quick Heal Technologies share price today: ₹144.70 at the NSE close on 3 November 2026, down 54.4% in a year. Quick Heal Technologies (NSE: QUICKHEAL) is worth ₹787 crore, trades at a P/E of 196.4 and has closed between ₹132.57 and ₹317.95 over the past 52 weeks. > Quick Heal Technologies Ltd's share price has risen faster than its earnings: −54.4% in a year, against −316.1% for earnings per share. QUICKHEAL · IT - Software · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/quick-heal-technologies-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting worse, from the last 12 quarters
- Price: ₹144.70 (−54.4% in a year)
- P/E: 196.4× (higher than 100% of the last 10 years)
- Revenue (Sep 2026): ₹64.9 Cr (−22.3% on a year ago)
- Profit (Sep 2026): ₹5.8 Cr (−26.7% on a year ago)
- Operating margin: 3.5% (−7.5 points on a year ago)
- ROCE: −6%, FY26
- ROIC: −26.6%, against a 12.0% cost of capital: −38.6 points

The main question: the share price moved −54.4% in a year while yearly earnings per share moved −316.1%. The difference came from the market paying a higher multiple. ## What is the Quick Heal Technologies share price today? Quick Heal Technologies Ltd's share price was ₹144.70 at the close on 3 November 2026. It has been falling for 90 weeks. That is 20.5% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹133 and ₹318, and at that close it sat 7% of the way up from that low. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 2 weeks in a row. Over the last 11 years the share price moved −27% while the NIFTY 500 moved +257%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Quick Heal Technologies this quarter? 5 points on a year earlier. 1. Promoters cut their stake for 13 quarters in a row From 73.1% to 71.5% of the company by the September 2026 quarter. 2. Operating margin down 7.5 points on a year earlier 3.5% in the September 2026 quarter, from 11.1%. Why: The margin fell because revenue was down 22% from a year earlier while total spending excluding depreciation stayed flat. Next results: check whether enterprise orders already booked turn into sales and narrow the drop in yearly revenue. From the earnings call on 28 Oct 2026. ## What are Quick Heal Technologies' latest quarterly results? For July to September 2026 (the quarter ended 30 September 2026), Quick Heal Technologies reported revenue of ₹64.9 crore, down 22.3% from ₹83.5 crore a year earlier, and a profit of ₹5.80 crore, down 26.7% from ₹7.91 crore. ### Quick Heal Technologies results: July to September 2026 against a year earlier

| Measure | July to September 2026 | July to September 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹64.9 crore | ₹83.5 crore | −22.3% |
| Profit | ₹5.80 crore | ₹7.91 crore | −26.7% |
| Earnings per share | ₹1.07 | ₹1.46 | −26.7% |
| Operating margin | 3.5% | 11.1% | −7.5 points |

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). Quick Heal Technologies' management discussed these results on a call held on 28 October 2026; what it said is further down this page. (From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.)

## What is the Quick Heal Technologies share price history? Quick Heal Technologies closed at ₹144.70 on 3 November 2026, down 54.4% from ₹317.50 a year earlier (31 October 2025) and down 37.4% over five years. Its highest weekly close since February 2016 was ₹811.70 on 11 October 2024. ### Quick Heal Technologies share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹138.38 | +4.6% |
| 1 month ago · 1 Oct 2026 | ₹138.15 | +4.7% |
| 6 months ago · 30 Apr 2026 | ₹166.58 | −13.1% |
| 1 year ago · 31 Oct 2025 | ₹317.50 | −54.4% |
| 3 years ago · 3 Nov 2023 | ₹320.90 | −54.9% |
| 5 years ago · 4 Nov 2021 | ₹231.30 | −37.4% |
| 10 years ago · 4 Nov 2016 | ₹232.95 | −37.9% |
| Earliest weekly close in our records · 26 Feb 2016 | ₹196.95 | −26.5% |
| Highest weekly close since February 2016 · 11 Oct 2024 | ₹811.70 | −82.2% |
| Lowest weekly close since February 2016 · 27 Mar 2020 | ₹71.95 | +101.1% |
| 52-week high (weekly close) · 14 Nov 2025 | ₹317.95 | −54.5% |
| 52-week low (weekly close) · 27 Mar 2026 | ₹132.57 | +9.1% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (565 weekly closes from 26 February 2016 to 3 November 2026.)

## What is the latest news on Quick Heal Technologies? 3 Nov 2026: Quick Heal Technologies closed at ₹144.70, up 4.6% on the week and up 4.7% on the month. 28 Oct 2026: Quick Heal Technologies held its results call for July to September 2026. Management guided: Enterprise contribution to grow beyond 80% in at least coming 3 years. ### Earlier

- Results for July to September 2026: Revenue down 22.3% and profit down 26.7% on a year earlier. ## What dividend does Quick Heal Technologies pay? Quick Heal Technologies paid no dividend in the 12 months to 4 November 2026. The last was a dividend of ₹3 a share, ex-date 30 August 2024. ### Quick Heal Technologies dividends since 1 April 2021

| Ex-date | Dividend per share | Type | Record date |
| --- | --- | --- | --- |
| 30 Aug 2024 | ₹3 | Dividend | n/a |
| 28 Jul 2023 | ₹2.50 | Dividend | same day |
| 18 Aug 2022 | ₹4.50 | Dividend | n/a |
| 29 Jul 2021 | ₹4 | Dividend | 30 Jul 2021 |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. 4 of 5 Of the last 5 financial years, years with an NSE dividend record

Not in its latest year. Quick Heal Technologies Ltd paid out 0% of its profit as dividends in FY26. It did pay a dividend in 11 of its last 13 reported years, so there is a history but no current dividend. (From the NSE corporate-actions record, read 4 November 2026.)

## What did Quick Heal Technologies management say on the latest results call? On the call for July to September 2026, held on 28 October 2026, Quick Heal Technologies' management guided: Enterprise contribution to grow beyond 80% in at least coming 3 years. > “The traction is that, over at least the coming 3 years, we anticipate that the contribution from enterprise will grow beyond 80%”
> Dr. Sanjay Katkar, on the call for July to September 2026

### What management guided

- Seqrite Data Privacy to match endpoint scale over medium to long term. - Employee cost to remain in similar range with selective adds where gaps exist. - International to build meaningful positions in fewer markets rather than spread thin. - Consumer near-term volume to stay moderated under tightened credit to improve quality and discipline. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijoristack.ai/concall/transcript/6768-28-Oct-2026.pdf). (From the call for July to September 2026, 28 October 2026.)

## What to watch in Quick Heal Technologies' next results? When Quick Heal Technologies reports October to December 2026, these are the 3 checks that show whether the story is still on course. First: Enterprise recognised revenue sustains on the previous quarter rebound and narrows on a year earlier decline as flagged deferred and order cover converts to sales. - What to check (from the call)
- Enterprise recognised revenue sustains on the previous quarter rebound and narrows on a year earlier decline as flagged deferred and order cover converts to sales. - Total receivables decline further from improved level on continued tightened credit and commercial discipline with partners. - Seqrite Data Privacy secures new enterprise and public-sector references proving repeatable sales motion beyond endpoint. ## Which stock lists is Quick Heal Technologies on? Quick Heal Technologies is on one of our India lists: IT stocks. [IT stocks Market value (₹ crore): 793.2408390521817](https://www.sectoralpha.in/sectors/it-stocks-india)

## Is Quick Heal Technologies profitable? Quick Heal Technologies Ltd earned ₹5.8 Cr of net profit in the Sep 2026 quarter, −26.7% on the same quarter a year earlier. The full FY26 year was a loss of ₹11.0 Cr. That is 8.9% of the quarter's revenue. The same quarter a year earlier earned ₹7.9 Cr. 4 of the last 12 reported quarters were loss-making. For the full year, FY26 profit was −₹11.0 Cr (−320.0% on the year before). ## How much revenue does Quick Heal Technologies make, and is it growing? Quick Heal Technologies Ltd reported ₹64.9 Cr of revenue in the Sep 2026 quarter, −22.3% on the same quarter a year earlier. Over 10 years it has grown −1.4% a year on average. The last full year, FY26, came in at ₹261 Cr. The last four reported quarters add to ₹230 Cr. FY26 revenue was ₹261 Cr, −6.8% on the year before. Recent pace: the last four quarters grew −16.9% on average, against −1.4% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew −16.7%, against −13.2% a year over the last 8 quarters (rolling over). ## How much of every ₹100 of sales does Quick Heal Technologies keep? Quick Heal Technologies Ltd's operating margin was 3.5% in the Sep 2026 quarter, 7.5 percentage points lower than the same quarter a year ago. Across 13 years it has been between −11.0% and 42.0%. The latest quarter is within that range. Why the margin moved: operating margin changed −7.5 percentage points on the year while gross margin changed +1.4 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is Quick Heal Technologies' profit turning into cash? Over the last 3 years, 77% of Quick Heal Technologies Ltd's reported profit came in as cash from its operations, so most of the profit is real cash. In FY26 it brought in ₹15.0 Cr of operating cash against −₹11.0 Cr of profit. After ₹17.0 Cr of spending on assets, free cash was −₹2.0 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Quick Heal Technologies' cash go? Quick Heal Technologies Ltd's customer, stock and supplier day counts come out in the thousands of days on sales this small (₹261 Cr in FY26), so no cash-cycle chart is drawn and this section looks at its spending on assets instead. It spent ₹38.0 Cr on assets over the last 3 years. Averaged over those years that is 4.9% of FY26 revenue a year. Spending on assets: ₹38.0 Cr over the last 3 years, against ₹40.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is spending about what it takes to replace what wears out, or less. Work still in progress is ₹0.0 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Quick Heal Technologies' P/E ratio, and how does it compare with its own history? Quick Heal Technologies Ltd's P/E is 196.4×, about the highest it has ever been. Its usual P/E (the middle reading) is 19.3×, over 10 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −316.1% while the price moved −54.4%. The price did better than earnings, which pushed the multiple up within its own range. Where the price move came from: over 5 years the price moved −9.0% a year; about −38.1% a year came from earnings growth and about +29.1 percentage points from the multiple (the market paying more); over 10 years the price moved −4.7% a year; about −18.9% a year came from earnings growth and about +14.2 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Quick Heal Technologies business getting better or worse? Quick Heal Technologies Ltd's business is getting worse. Revenue, profit and EPS growth are shrinking: revenue growth is −16.7% in the latest quarter, against +24.5% at its best in 12 quarters, with ROCE steady at 0.6%. This is based on 12 quarters of 4 measures. Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind. ## How much does Quick Heal Technologies earn on its capital? Quick Heal Technologies Ltd earned a ROCE of −6% in FY26. Its return on capital used (ROIC) is 38.6 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a −4.2% net margin and 0.48× asset turnover (sales divided by assets). Why the return is what it is (FY26): a −4.2% net margin × 0.48× asset turnover × 1.25× leverage (assets divided by equity) ≈ −2.5% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: −26.6% − 12.0% = −38.6 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The −26.6% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at −16.3%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Quick Heal Technologies have too much debt? Quick Heal Technologies Ltd has total debt of ₹0.0 Cr against shareholder equity of ₹437 Cr as of Jun 2026, so its debt is 0.00× its equity, which is very little. Year by year, that ratio went from 0.00 in FY25 to 0.00 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the Quick Heal Technologies shareholding pattern? Domestic institutions cut their stake in Quick Heal Technologies Ltd by 2.6 percentage points over 8 quarters, the biggest change among its owners. Domestic institutions now own 0.0% of the company. Foreign institutions moved −1.2 points over the same period, to 0.4%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Domestic institutions: −2.6 points over 8 quarters, to 0.0%; Foreign institutions: −1.2 points over 8 quarters, to 0.4%; Promoters: −0.6 points over 8 quarters, to 71.5%. Why the owners changed: domestic institutions drove it (−2.6 points), together with foreign institutions (−1.2 points). They reduced their stake. ## How far is Quick Heal Technologies from balance-sheet trouble? For Quick Heal Technologies Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Quick Heal Technologies rank in its industry? 22.9 out of 100, rank 55 of 69 in IT - Software, with 80% of the evidence available. Quick Heal Technologies Ltd scores 22.9 out of 100 against the 69 companies it is compared with in IT - Software, ranking 55. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 2.9 + 1.3 + 10 + 8.7 = 22.9. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Quick Heal Technologies compared with? Quick Heal Technologies ranks 55 of 69 IT - Software companies on the 4-Factor Sector Score, with 22.9 out of 100. 1. [Coforge Ltd](https://www.sectoralpha.in/stocks/coforge-ltd) COFORGE · leader · Most evidence points up · 100% evidence 69.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.4/35 · Revenue 41.5% · Profit 56.3% · Operating margin change 1 points · 100% evidence Capital efficiency 16.5/25 · ROCE 23.5% · Operating margin 20% · 100% evidence Valuation 11.3/20 · P/E 41.7× · PEG 0.57 · 100% evidence Relative strength 18.5/20 · Lead over its industry 24.5% · Lead over NIFTY 500 35.5% · 1 year 15% · 100% evidence · 12 of 12 weeks ahead Exact sum: 23.4 + 16.5 + 11.3 + 18.5 = 69.7 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Expleo Solutions Ltd](https://www.sectoralpha.in/stocks/expleo-solutions-ltd) EXPLEOSOL · breaking out · Most evidence points up · 81% evidence 68.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.6/35 · Revenue 10.4% · Profit 39.4% · Operating margin change 4 points · 88% evidence Capital efficiency 15.4/25 · ROCE 24.2% · Operating margin 15% · 100% evidence Valuation 18.7/20 · P/E 8.5× · PEG 0.33 · 100% evidence Relative strength 9.6/20 · Lead over its industry n/a · Lead over NIFTY 500 -2.7% · 1 year -20.7% · 25% evidence · 8 of 12 weeks ahead Exact sum: 24.6 + 15.4 + 18.7 + 9.6 = 68.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Cigniti Technologies Ltd](https://www.sectoralpha.in/stocks/cigniti-technologies-ltd) CIGNITITEC · Too little evidence to rank firmly · 55% evidence 68.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.8/43.75 · Revenue 14% · Profit 96.1% · Operating margin change 2 points · 47% evidence Capital efficiency 20.9/31.25 · ROCE 34.1% · Operating margin 18% · 75% evidence Valuation 19.5/25 · P/E 11.4× · PEG 0.74 · 100% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 27.8 + 20.9 + 19.5 = 68.2 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 4. [Metalic Technoforge Ltd](https://www.sectoralpha.in/stocks/metalic-technoforge-ltd) META · turning · Too little evidence to rank firmly · 51% evidence 67.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 32.8/43.75 · Revenue 100% · Profit 100% · Operating margin change 0 points · 83% evidence Capital efficiency 20.2/31.25 · ROCE 44% · Operating margin 11% · 76% evidence Valuation 14.3/25 · P/E 6.6× · PEG n/a · 15% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 32.8 + 20.2 + 14.3 = 67.3 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 5. [Sahana Systems Ltd](https://www.sectoralpha.in/stocks/sahana-systems-ltd) SAHANA · leader · Too little evidence to rank firmly · 54% evidence 66.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.4/35 · Revenue 100% · Profit 100% · Operating margin change -3 points · 27% evidence Capital efficiency 18.4/25 · ROCE 39.8% · Operating margin 29% · 57% evidence Valuation 12.0/20 · P/E 14.5× · PEG n/a · 50% evidence Relative strength 17.2/20 · Lead over its industry 12.3% · Lead over NIFTY 500 22.7% · 1 year 5.7% · 100% evidence · 12 of 12 weeks ahead Exact sum: 18.4 + 18.4 + 12 + 17.2 = 66 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 6. [Silver Touch Technologies Ltd](https://www.sectoralpha.in/stocks/silver-touch-technologies-ltd) SILVERTUC · quiet · Most evidence points up · 100% evidence 65.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 29.9/35 · Revenue 21.7% · Profit 88% · Operating margin change 5 points · 100% evidence Capital efficiency 21.3/25 · ROCE 29.8% · Operating margin 21% · 100% evidence Valuation 11.2/20 · P/E 31.6× · PEG 1.11 · 100% evidence Relative strength 3.0/20 · Lead over its industry -21.7% · Lead over NIFTY 500 -13.9% · 1 year 52.9% · 100% evidence · 2 of 12 weeks ahead Exact sum: 29.9 + 21.3 + 11.2 + 3 = 65.4 · What this means: Earnings are strong; relative strength in its sector is -21.7% and the one-year return is 52.9%. 7. [NINtec Systems Ltd](https://www.sectoralpha.in/stocks/nintec-systems-ltd) NINSYS · turning · Most evidence points up · 93% evidence 65.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.2/35 · Revenue 18.8% · Profit 23.3% · Operating margin change 2 points · 100% evidence Capital efficiency 22.4/25 · ROCE 54% · Operating margin 27% · 100% evidence Valuation 6.6/20 · P/E 48.1× · PEG 2.08 · 65% evidence Relative strength 18.2/20 · Lead over its industry 57.5% · Lead over NIFTY 500 70.4% · 1 year 113.7% · 100% evidence · 4 of 12 weeks ahead Exact sum: 18.2 + 22.4 + 6.6 + 18.2 = 65.4 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 8. [Unified Data- Tech Solutions Ltd](https://www.sectoralpha.in/stocks/unified-data-tech-solutions-ltd) breaking out · Too little evidence to rank firmly · 56% evidence 63.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.0/35 · Revenue n/a · Profit n/a · Operating margin change 2 points · 26% evidence Capital efficiency 18.4/25 · ROCE 34.1% · Operating margin 15% · 95% evidence Valuation 10.2/20 · P/E 17.3× · PEG n/a · 15% evidence Relative strength 17.8/20 · Lead over its industry 11.5% · Lead over NIFTY 500 22% · 1 year -7.6% · 100% evidence · 8 of 12 weeks ahead Exact sum: 17 + 18.4 + 10.2 + 17.8 = 63.4 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 9. [ASM Technologies Ltd](https://www.sectoralpha.in/stocks/asm-technologies-ltd) leader · Evidence leans up · 61% evidence 63.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 26.1/35 · Revenue 67.8% · Profit 89.5% · Operating margin change 2 points · 83% evidence Capital efficiency 16.0/25 · ROCE 27% · Operating margin 23% · 95% evidence Valuation 8.7/20 · P/E 124× · PEG n/a · 15% evidence Relative strength 12.3/20 · Lead over its industry n/a · Lead over NIFTY 500 66.2% · 1 year 78.6% · 25% evidence · 12 of 12 weeks ahead Exact sum: 26.1 + 16 + 8.7 + 12.3 = 63.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Tanla Platforms Ltd](https://www.sectoralpha.in/stocks/tanla-platforms-ltd) TANLA · turning · Evidence leans up · 85% evidence 62.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.7/35 · Revenue 17.7% · Profit 15.4% · Operating margin change 0 points · 100% evidence Capital efficiency 18.4/25 · ROCE 26.3% · Operating margin 16% · 100% evidence Valuation 14.0/20 · P/E 15× · PEG 1.07 · 100% evidence Relative strength 11.7/20 · Lead over its industry n/a · Lead over NIFTY 500 26.7% · 1 year 2.8% · 25% evidence · 3 of 12 weeks ahead Exact sum: 18.7 + 18.4 + 14 + 11.7 = 62.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [String Metaverse Ltd](https://www.sectoralpha.in/stocks/string-metaverse-ltd) breaking out · Evidence leans up · 83% evidence 62.5 out of 100 Growth Capital Valuation Relative
12. [Tech Mahindra Ltd](https://www.sectoralpha.in/stocks/tech-mahindra-ltd) TECHM · leader · Evidence leans up · 85% evidence 62.1 out of 100 Growth Capital Valuation Relative
13. [Infosys Ltd](https://www.sectoralpha.in/stocks/infosys-ltd) INFY · breaking out · Evidence leans up · 82% evidence 61.7 out of 100 Growth Capital Valuation Relative
14. [InfoBeans Technologies Ltd](https://www.sectoralpha.in/stocks/infobeans-technologies-ltd) INFOBEAN · quiet · Evidence leans up · 100% evidence 61.6 out of 100 Growth Capital Valuation Relative
15. [Zensar Technologies Ltd](https://www.sectoralpha.in/stocks/zensar-technologies-ltd) ZENSARTECH · turning · Evidence leans up · 100% evidence 61.6 out of 100 Growth Capital Valuation Relative
16. [Tata Consultancy Services Ltd](https://www.sectoralpha.in/stocks/tata-consultancy-services-ltd) TCS · breaking out · Evidence leans up · 100% evidence 60.9 out of 100 Growth Capital Valuation Relative
17. [Sasken Technologies Ltd](https://www.sectoralpha.in/stocks/sasken-technologies-ltd) SASKEN · turning · Evidence leans up · 100% evidence 60.8 out of 100 Growth Capital Valuation Relative
18. [Birlasoft Ltd](https://www.sectoralpha.in/stocks/birlasoft-ltd) BSOFT · breaking out · Evidence leans up · 100% evidence 59.6 out of 100 Growth Capital Valuation Relative
19. [Seshaasai Technologies Ltd](https://www.sectoralpha.in/stocks/seshaasai-technologies-ltd) STYL · quiet · Evidence leans up · 68% evidence 59.6 out of 100 Growth Capital Valuation Relative
20. [Xchanging Solutions Ltd](https://www.sectoralpha.in/stocks/xchanging-solutions-ltd) XCHANGING · quiet · Evidence leans up · 85% evidence 59.1 out of 100 Growth Capital Valuation Relative
21. [RNIT AI Solutions Ltd](https://www.sectoralpha.in/stocks/rnit-ai-solutions-ltd) AUTOPALIND · breaking out · Evidence leans up · 69% evidence 59.1 out of 100 Growth Capital Valuation Relative
22. [Danlaw Technologies India Ltd](https://www.sectoralpha.in/stocks/danlaw-technologies-india-ltd) breaking out · Evidence leans up · 68% evidence 58.8 out of 100 Growth Capital Valuation Relative
23. [Softtech Engineers Ltd](https://www.sectoralpha.in/stocks/softtech-engineers-ltd) SOFTTECH · breaking out · Evidence leans up · 79% evidence 58.3 out of 100 Growth Capital Valuation Relative
24. [R Systems International Ltd](https://www.sectoralpha.in/stocks/r-systems-international-ltd) RSYSTEMS · losing its lead · Evidence leans up · 96% evidence 57.1 out of 100 Growth Capital Valuation Relative
25. [HCL Technologies Ltd](https://www.sectoralpha.in/stocks/hcl-technologies-ltd) HCLTECH · leader · Evidence leans up · 82% evidence 56.7 out of 100 Growth Capital Valuation Relative
26. [Datamatics Global Services Ltd](https://www.sectoralpha.in/stocks/datamatics-global-services-ltd) DATAMATICS · quiet · Evidence leans up · 81% evidence 55.8 out of 100 Growth Capital Valuation Relative
27. [Wipro Ltd](https://www.sectoralpha.in/stocks/wipro-ltd) WIPRO · turning · Evidence leans up · 100% evidence 55.4 out of 100 Growth Capital Valuation Relative
28. [Subex Ltd](https://www.sectoralpha.in/stocks/subex-ltd) SUBEXLTD · breaking out · Evidence leans up · 64% evidence 54.2 out of 100 Growth Capital Valuation Relative
29. [Ksolves India Ltd](https://www.sectoralpha.in/stocks/ksolves-india-ltd) KSOLVES · quiet · Evidence leans up · 100% evidence 52.8 out of 100 Growth Capital Valuation Relative
30. [Capillary Technologies India Ltd](https://www.sectoralpha.in/stocks/capillary-technologies-india-ltd) CAPILLARY · breaking out · Too little evidence to rank firmly · 59% evidence 52.6 out of 100 Growth Capital Valuation Relative
31. [LTM Ltd](https://www.sectoralpha.in/stocks/ltm-ltd) LTM · losing its lead · Evidence leans up · 100% evidence 51.2 out of 100 Growth Capital Valuation Relative
32. [TechNVision Ventures Ltd](https://www.sectoralpha.in/stocks/technvision-ventures-ltd) TECHNVISN · quiet · Evidence leans up · 64% evidence 51.2 out of 100 Growth Capital Valuation Relative
33. [Saksoft Ltd](https://www.sectoralpha.in/stocks/saksoft-ltd) SAKSOFT · basing · Evidence leans up · 96% evidence 50.9 out of 100 Growth Capital Valuation Relative
34. [BLS E-Services Ltd](https://www.sectoralpha.in/stocks/bls-e-services-ltd) BLSE · leader · Evidence leans up · 78% evidence 50.5 out of 100 Growth Capital Valuation Relative
35. [Mphasis Ltd](https://www.sectoralpha.in/stocks/mphasis-ltd) MPHASIS · breaking out · Evidence leans up · 81% evidence 50.4 out of 100 Growth Capital Valuation Relative
36. [Excelsoft Technologies Ltd](https://www.sectoralpha.in/stocks/excelsoft-technologies-ltd) EXCELSOFT · breaking out · Too little evidence to rank firmly · 59% evidence 50.3 out of 100 Growth Capital Valuation Relative
37. [Blue Cloud Softech Solutions Ltd](https://www.sectoralpha.in/stocks/blue-cloud-softech-solutions-ltd) BLUECLOUDS · turning · Evidence leans down · 64% evidence 49.9 out of 100 Growth Capital Valuation Relative
38. [ACS Technologies Ltd](https://www.sectoralpha.in/stocks/acs-technologies-ltd) ACSTECH · Evidence leans down · 74% evidence 49.5 out of 100 Growth Capital Valuation Relative
39. [Magellanic Cloud Ltd](https://www.sectoralpha.in/stocks/magellanic-cloud-ltd) MCLOUD · basing · Evidence leans down · 81% evidence 49.2 out of 100 Growth Capital Valuation Relative
40. [Dynacons Systems & Solutions Ltd](https://www.sectoralpha.in/stocks/dynacons-systems-solutions-ltd) DSSL · quiet · Evidence leans down · 96% evidence 48.6 out of 100 Growth Capital Valuation Relative
41. [IZMO Ltd](https://www.sectoralpha.in/stocks/izmo-ltd) IZMO · quiet · Evidence leans down · 81% evidence 48.0 out of 100 Growth Capital Valuation Relative
42. [Mastek Ltd](https://www.sectoralpha.in/stocks/mastek-ltd) MASTEK · quiet · Evidence leans down · 100% evidence 47.1 out of 100 Growth Capital Valuation Relative
43. [Sonata Software Ltd](https://www.sectoralpha.in/stocks/sonata-software-ltd) SONATSOFTW · quiet · Evidence leans down · 96% evidence 46.9 out of 100 Growth Capital Valuation Relative
44. [AvenuesAI Ltd](https://www.sectoralpha.in/stocks/avenuesai-ltd) CCAVENUE · quiet · Evidence leans down · 89% evidence 44.8 out of 100 Growth Capital Valuation Relative
45. [Unicommerce eSolutions Ltd](https://www.sectoralpha.in/stocks/unicommerce-esolutions-ltd) UNIECOM · turning · Evidence leans down · 78% evidence 44.6 out of 100 Growth Capital Valuation Relative
46. [Hexaware Technologies Ltd](https://www.sectoralpha.in/stocks/hexaware-technologies-ltd) HEXT · basing · Evidence leans down · 85% evidence 42.0 out of 100 Growth Capital Valuation Relative
47. [Allied Digital Services Ltd](https://www.sectoralpha.in/stocks/allied-digital-services-ltd) ADSL · basing · Evidence leans down · 74% evidence 41.1 out of 100 Growth Capital Valuation Relative
48. [Hypersoft Technologies Ltd](https://www.sectoralpha.in/stocks/hypersoft-technologies-ltd) quiet · Evidence leans down · 80% evidence 40.9 out of 100 Growth Capital Valuation Relative
49. [Kellton Tech Solutions Ltd](https://www.sectoralpha.in/stocks/kellton-tech-solutions-ltd) KELLTONTEC · quiet · Evidence leans down · 96% evidence 39.0 out of 100 Growth Capital Valuation Relative
50. [3i Infotech Ltd](https://www.sectoralpha.in/stocks/3i-infotech-ltd) 3IINFOLTD · Too little evidence to rank firmly · 58% evidence 38.9 out of 100 Growth Capital Valuation Relative
51. [Innovana Thinklabs Ltd](https://www.sectoralpha.in/stocks/innovana-thinklabs-ltd) INNOVANA · basing · Evidence leans down · 81% evidence 37.6 out of 100 Growth Capital Valuation Relative
52. [Mindteck (India) Ltd](https://www.sectoralpha.in/stocks/mindteck-indialtd) MINDTECK · Most evidence points down · 76% evidence 32.8 out of 100 Growth Capital Valuation Relative
53. [Aurionpro Solutions Ltd](https://www.sectoralpha.in/stocks/aurionpro-solutions-ltd) AURIONPRO · basing · Most evidence points down · 93% evidence 29.7 out of 100 Growth Capital Valuation Relative
54. [Moschip Technologies Ltd](https://www.sectoralpha.in/stocks/moschip-technologies-ltd) MOSCHIP · quiet · Most evidence points down · 65% evidence 26.1 out of 100 Growth Capital Valuation Relative
55. Quick Heal Technologies Ltd this page QUICKHEAL · turning · Most evidence points down · 80% evidence 22.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 2.9/35 · Revenue -16.8% · Profit -80% · Operating margin change -7.5 points · 100% evidence Capital efficiency 1.3/25 · ROCE -6% · Operating margin 3.5% · 100% evidence Valuation 10.0/20 · P/E n/a · PEG n/a · 0% evidence Relative strength 8.7/20 · Lead over its industry -21.1% · Lead over NIFTY 500 -13.4% · 1 year -51.4% · 100% evidence · 1 of 12 weeks ahead Exact sum: 2.9 + 1.3 + 10 + 8.7 = 22.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 56. Orient Technologies Ltd ORIENTTECH · quiet · Most evidence points down · 76% evidence 21.2 out of 100 Growth Capital Valuation Relative
57. [Covance Softsol Ltd](https://www.sectoralpha.in/stocks/covance-softsol-ltd) Too little evidence to rank firmly · 31% evidence 62.9 out of 100 Growth Capital Valuation Relative
58. [Exato Technologies Ltd](https://www.sectoralpha.in/stocks/exato-technologies-ltd) losing its lead · Too little evidence to rank firmly · 43% evidence 59.3 out of 100 Growth Capital Valuation Relative
59. [TAC Infosec Ltd](https://www.sectoralpha.in/stocks/tac-infosec-ltd) TAC · quiet · Too little evidence to rank firmly · 48% evidence 58.5 out of 100 Growth Capital Valuation Relative
60. [Veefin Solutions Ltd](https://www.sectoralpha.in/stocks/veefin-solutions-ltd) VEEFIN · basing · Too little evidence to rank firmly · 43% evidence 54.2 out of 100 Growth Capital Valuation Relative
61. [Kody Technolab Ltd](https://www.sectoralpha.in/stocks/kody-technolab-ltd) KODYTECH · leader · Too little evidence to rank firmly · 35% evidence 53.5 out of 100 Growth Capital Valuation Relative
62. [Optivalue Tek Consulting Ltd](https://www.sectoralpha.in/stocks/optivalue-tek-consulting-ltd) OPTIVALUE · Too little evidence to rank firmly · 32% evidence 51.4 out of 100 Growth Capital Valuation Relative
63. [Workmates Core2cloud Solution Ltd](https://www.sectoralpha.in/stocks/workmates-core2cloud-solution-ltd) Too little evidence to rank firmly · 26% evidence 50.7 out of 100 Growth Capital Valuation Relative
64. [Trident Techlabs Ltd](https://www.sectoralpha.in/stocks/trident-techlabs-ltd) TECHLABS · Too little evidence to rank firmly · 27% evidence 47.6 out of 100 Growth Capital Valuation Relative
65. [ERP Soft Systems Ltd](https://www.sectoralpha.in/stocks/erp-soft-systems-ltd) Too little evidence to rank firmly · 36% evidence 46.7 out of 100 Growth Capital Valuation Relative
66. [Sancode Technologies Ltd](https://www.sectoralpha.in/stocks/sancode-technologies-ltd) Too little evidence to rank firmly · 35% evidence 46.6 out of 100 Growth Capital Valuation Relative
67. [63 Moons Technologies Ltd](https://www.sectoralpha.in/stocks/63-moons-technologies-ltd) 63MOONS · leader · Too little evidence to rank firmly · 46% evidence 45.6 out of 100 Growth Capital Valuation Relative
68. [XT Global Infotech Ltd](https://www.sectoralpha.in/stocks/xt-global-infotech-ltd) XTGLOBAL · Too little evidence to rank firmly · 40% evidence 45.4 out of 100 Growth Capital Valuation Relative
69. [IDream Film Infrastructure Company Ltd](https://www.sectoralpha.in/stocks/idream-film-infrastructure-company-ltd) quiet · Too little evidence to rank firmly · 42% evidence 34.9 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [IT - Software](https://www.sectoralpha.in/sectors/it-software), all 69 compared on one page. ## Which companies are close to Quick Heal Technologies in size? Quick Heal Technologies is the 46th largest of 68 IT - Software companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Unified Data- Tech Solutions, Unicommerce eSolutions and RNIT AI Solutions. Just below it: Sancode Technologies, String Metaverse and Metalic Technoforge. ### IT - Software companies close in size

1. [Unified Data- Tech Solutions Ltd](https://www.sectoralpha.in/stocks/unified-data-tech-solutions-ltd) ₹896 crore
2. [Unicommerce eSolutions Ltd](https://www.sectoralpha.in/stocks/unicommerce-esolutions-ltd) ₹893 crore
3. [RNIT AI Solutions Ltd](https://www.sectoralpha.in/stocks/rnit-ai-solutions-ltd) ₹839 crore
4. Quick Heal Technologies Ltd ₹838 crore
5. [Sancode Technologies Ltd](https://www.sectoralpha.in/stocks/sancode-technologies-ltd) ₹832 crore
6. [String Metaverse Ltd](https://www.sectoralpha.in/stocks/string-metaverse-ltd) ₹808 crore
7. [Metalic Technoforge Ltd](https://www.sectoralpha.in/stocks/metalic-technoforge-ltd) ₹805 crore

[All 68 IT - Software companies, largest first](https://www.sectoralpha.in/sectors/it-software#all-companies)

### Companies close in size in other industries

1. [Uni Abex Alloy Products Ltd](https://www.sectoralpha.in/stocks/uni-abex-alloy-products-ltd) ₹841 crore · Castings, Forgings & Fastners
2. [RNIT AI Solutions Ltd](https://www.sectoralpha.in/stocks/rnit-ai-solutions-ltd) ₹839 crore · IT - Software
3. Quick Heal Technologies Ltd ₹838 crore
4. [Jindal Supreme (India) Ltd](https://www.sectoralpha.in/stocks/jindal-supreme-indialtd) ₹836 crore
5. [Hemant Surgical Industries Ltd](https://www.sectoralpha.in/stocks/hemant-surgical-industries-ltd) ₹834 crore · Medical Equipment

## What else do people ask about Quick Heal Technologies? ### What is Quick Heal Technologies's share price today? Quick Heal Technologies Ltd's share price is ₹144.70, −54.4% over the past year. The whole company is worth ₹787 Cr on the market. In the last 52 weeks it traded between ₹133 to ₹318; today it is 7% of the way up from the low, 20.5% below its 200-day average (as of 3 November 2026). ### What were Quick Heal Technologies's latest quarterly results? Quick Heal Technologies Ltd reported revenue of ₹64.9 Cr and net profit of ₹5.8 Cr for the Sep 2026 quarter. Revenue fell 22.3% and profit fell 26.7% compared with a year earlier. Earnings per share were ₹1.07. The operating margin was 3.5%, 7.5 percentage points lower than a year earlier (as of 3 November 2026). ### What is Quick Heal Technologies's market cap? Quick Heal Technologies Ltd's market capitalisation is ₹787 Cr at a share price of ₹144.70. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Quick Heal Technologies performing? Quick Heal Technologies Ltd's share price has been falling for 90 weeks. In its latest quarter, revenue fell 22.3% and profit fell 26.7% compared with a year earlier. Over the past 13 weeks it has done better than the NIFTY 500, for 2 weeks running (as of 3 November 2026). ### Will Quick Heal Technologies's share price go up? This page does not forecast Quick Heal Technologies Ltd's share price. What it shows instead: the share price is ₹144.70, and it has been falling for 90 weeks. Its P/E of 196.4× is higher than 100% of its own last 10 years (as of 3 November 2026). ### Who owns Quick Heal Technologies? Promoters own 71.5% of Quick Heal Technologies Ltd, foreign institutions 0.4%, domestic institutions 0.0% and the public 28.2% (latest quarter). The biggest change over the last two years: Domestic institutions cut their stake by 2.6 percentage points over 8 quarters (as of 3 November 2026). ### Does Quick Heal Technologies have too much debt? No, Quick Heal Technologies Ltd has little debt: its debt is 0.00× its equity. FY26 borrowings were ₹0.0 Cr against equity of ₹436 Cr. So the returns on this page come from the business, not borrowed money (as of 3 November 2026). ### Where is Quick Heal Technologies in its business cycle? Quick Heal Technologies Ltd's FY26 operating margin was −11.0%, against a 13-year range of −11.0% to 42.0%: the low end of its own range, which is often where recoveries start. The latest quarter was 3.5%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Quick Heal Technologies story? The main question: the share price moved −54.4% in a year while yearly earnings per share moved −316.1%. The difference came from the market paying a higher multiple. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Quick Heal Technologies a stock worth studying right now? What the numbers show: Quick Heal Technologies Ltd's share price has risen faster than its earnings: −54.4% in a year, against −316.1% for earnings per share. The main open question: whether earnings grow into a price that has already moved. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ### Is there a Quick Heal Technologies share price forecast for 2026? What management itself guided: Enterprise contribution to grow beyond 80% in at least coming 3 years. ## Lists

- IT stocks: https://www.sectoralpha.in/sectors/it-stocks-india

This is research, not advice. We’re not SEBI-registered.